Skip to content

Early Prediction of Sepsis

Early Prediction of Sepsis in Hospitalized Patients Using a Machine Learning Algorithm, a Randomized Clinical Validation Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04570618
Acronym
ExPRESS
Enrollment
320
Registered
2020-09-30
Start date
2020-12-01
Completion date
2021-11-01
Last updated
2021-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

Prediction

Brief summary

In this clinical trial a novel Medical Device Software will be validated prospectively. The software incorporates a machine learning algorithm capable of predicting sepsis by using routine clinical variables in adult patients at Intensive Care Units.

Interventions

DEVICEUnblinded AlgoDx Sepsis Prediction Algorithm

When applicable, a sepsis prediction alert is displayed in the AlgoDx Medical Device Software.

OTHERBlinded AlgoDx Sepsis Prediction Algorithm

Standard of Care, i.e. no sepsis prediction alert.

Sponsors

AlgoDx
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patient (age ≥18 years). 2. Patient is admitted to the ICU during the recruitment period of the trial.

Exclusion criteria

1. Patient is participating in another interventional clinical trial which, as judged by the investigator, could potentially impact variables used by the sepsis prediction algorithm or has participated in such interventional clinical trial within the last 30 days. 2. Patient is known to be pregnant. 3. Death is deemed imminent and inevitable, at the investigator's discretion. 4. Patient has, due to chronic reduced mental capacity, been assessed by the investigator as incapable of making an informed decision 5. Patient has previously been enrolled in this trial.

Design outcomes

Primary

MeasureTime frameDescription
Validate the prognostic accuracy of the algorithm at predicting sepsis.Up to 30 days (ICU hospitalization period)In order to clinically validate the sepsis prediction performance the following endpoints have been selected: * accuracy, * specificity, and * sensitivity of the AlgoDx Sepsis Prediction Algorithm in the SoC group (not possible to assess these in the SoC + Algorithm cohort).

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026